Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Kirk © who wrote (14047)	6/14/2022 12:07:27 PM
From: w0z	1 Recommendation Recommended By Kirk © Read Replies (2) \| Respond to of 26408

There is actually progress in that trial in that they are recommending 0.4 mg Ivermectin for 3 days. However this is still short of the FLCCC Early Treatment Protocol (as of 1/20/2022) which calls for: 0.4–0.6 mg/kg* per dose (take with or after a meal) — one dose daily,* take for 5 days or until recovered. Use upper dose (0.6 mg/kg) if: 1) in regions with aggressive variants (e.g. Delta); 2) treatment started on or after day 5 of symptoms or in pulmonary phase; or 3) multiple comorbidities/risk factors. The other issue I have with most (all?) IVM trials is that other parts of the protocol are not included. Especially important is taking zinc (and Vitamin D). Ivermectin, Hydroxychloroquine and Quercetin (OTC) are all zinc ionophores which facilitate absorption of zinc into tissues. Zinc is the bullet and zinc ionophores are the gun...i.e. both are necessary. I'm afraid many IVM trials are intentionally structured to demonstrate failure. I'd like to see the "Funding information for the ACTIV-6 study is included in the manuscript." but was unable to quickly locate it. The last time I checked with my wife's doc he had treated >120 patients diagnosed with covid with zero deaths and one hospitalization. I believe he mostly follows the FLCCC protocol. covid19criticalcare.com